ROLE OF HUMAN CYTOCHROME-P-450S IN RISK ASSESSMENT AND SUSCEPTIBILITY TO ENVIRONMENTALLY BASED DISEASE

被引:48
作者
GONZALEZ, FJ
GELBOIN, HV
机构
[1] National Cancer Institute, National Institutes of Health, Bethesda, MD
来源
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH | 1993年 / 40卷 / 2-3期
基金
美国国家卫生研究院;
关键词
D O I
10.1080/15287399309531795
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Cytochromes P-450 (P-450s) are a large group of heme-containing proteins that carry out oxidation of numerous chemicals. In mammals, a limited number of P-450s are involved in metabolic pathways of steroid synthesis, while most of these enzymes are involved in metabolism of foreign compounds. The principal beneficial function of P-450s is to convert chemicals into derivatives that can be easily eliminated from the body. This generally occurs through P-450-mediated oxidations of hydrophobic substances followed by conjugation reactions. For many foreign compounds, P-450 metabolism results in production of ''activated'' metabolites that can cause cell death and gene mutations. During the past several years, it has become widely recognized that marked species differences occur among the foreign compound-metabolizing P-450s. In addition to this interspecies variability in metabolism, marked intraspecies variability, frequently referred to as drug oxidation polymorphisms, occurs in virtually all mammals examined to date. Based on these observations, it is necessary to develop new human P-450-based systems that can be used to study foreign compound metabolism in order to predict human risk. This is being accomplished by use of cDNA-directed expression in B lymphoblastoid cells. These cells can be used to predict how humans will metabolize a chemical and whether it will be metabolically activated to a toxic or mutagenic metabolite. To study human P-450 polymorphisms, polymerase chain reaction (PCR) assays have been developed for diagnosis of known mutant P-450 genes. Molecular probes are also being used to screen populations for levels of expression of carcinogen-activating P-450s in an effort to determine whether expression of certain P-450 forms is associated with increased risk for development of environmentally based disease.
引用
收藏
页码:289 / 308
页数:20
相关论文
共 44 条
[1]   CLINICAL IMPLICATIONS OF VARIABLE ANTIARRHYTHMIC DRUG-METABOLISM [J].
BUCHERT, E ;
WOOSLEY, RL .
PHARMACOGENETICS, 1992, 2 (01) :2-11
[2]   HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J].
BUTLER, MA ;
IWASAKI, M ;
GUENGERICH, FP ;
KADLUBAR, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7696-7700
[3]   DETERMINATION OF CYP1A2 AND NAT2 PHENOTYPES IN HUMAN-POPULATIONS BY ANALYSIS OF CAFFEINE URINARY METABOLITES [J].
BUTLER, MA ;
LANG, NP ;
YOUNG, JF ;
CAPORASO, NE ;
VINEIS, P ;
HAYES, RB ;
TEITEL, CH ;
MASSENGILL, JP ;
LAWSEN, MF ;
KADLUBAR, FF .
PHARMACOGENETICS, 1992, 2 (03) :116-127
[4]   RELEVANCE OF METABOLIC POLYMORPHISMS TO HUMAN CARCINOGENESIS - EVALUATION OF EPIDEMIOLOGIC EVIDENCE [J].
CAPORASO, N ;
LANDI, MT ;
VINEIS, P .
PHARMACOGENETICS, 1991, 1 (01) :4-19
[5]   COMPARISON OF A NOVEL THIN-LAYER CHROMATOGRAPHIC-FLUORESCENCE DETECTION METHOD WITH A SPECTROFLUOROMETRIC METHOD FOR THE DETERMINATION OF 7-HYDROXYCOUMARIN IN HUMAN URINE [J].
CHOLERTON, S ;
IDLE, ME ;
VAS, A ;
GONZALEZ, FJ ;
IDLE, JR .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 575 (02) :325-330
[6]   A HOST-INDUCIBLE CYTOCHROME-P-450 FROM A HOST-SPECIFIC CATERPILLAR - MOLECULAR-CLONING AND EVOLUTION [J].
COHEN, MB ;
SCHULER, MA ;
BERENBAUM, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) :10920-10924
[7]   A TOBACCO SMOKE-DERIVED NITROSAMINE, 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, IS ACTIVATED BY MULTIPLE HUMAN CYTOCHROME P450S INCLUDING THE POLYMORPHIC HUMAN CYTOCHROME P4502D6 [J].
CRESPI, CL ;
PENMAN, BW ;
GELBOIN, HV ;
GONZALEZ, FJ .
CARCINOGENESIS, 1991, 12 (07) :1197-1201
[8]   THE DEVELOPMENT OF A HUMAN CELL-LINE STABLY EXPRESSING HUMAN CYP3A4 - ROLE IN THE METABOLIC-ACTIVATION OF AFLATOXIN-B1 AND COMPARISON TO CYP1A2 AND CYP2A3 [J].
CRESPI, CL ;
PENMAN, BW ;
STEIMEL, DT ;
GELBOIN, HV ;
GONZALEZ, FJ .
CARCINOGENESIS, 1991, 12 (02) :355-359
[9]   HUMAN CYTOCHROME P450IIA3 - CDNA SEQUENCE, ROLE OF THE ENZYME IN THE METABOLIC-ACTIVATION OF PROMUTAGENS, COMPARISON TO NITROSAMINE ACTIVATION BY HUMAN CYTOCHROME P450IIE1 [J].
CRESPI, CL ;
PENMAN, BW ;
LEAKEY, JAE ;
ARLOTTO, MP ;
STARK, A ;
PARKINSON, A ;
TURNER, T ;
STEIMEL, DT ;
RUDO, K ;
DAVIES, RL ;
LANGENBACH, R .
CARCINOGENESIS, 1990, 11 (08) :1293-1300
[10]   A METABOLICALLY COMPETENT HUMAN CELL-LINE EXPRESSING 5 CDNAS ENCODING PROCARCINOGEN-ACTIVATING ENZYMES - APPLICATION TO MUTAGENICITY TESTING [J].
CRESPI, CL ;
GONZALEZ, FJ ;
STEIMEL, DT ;
TURNER, TR ;
GELBOIN, HV ;
PENMAN, BW ;
LANGENBACH, R .
CHEMICAL RESEARCH IN TOXICOLOGY, 1991, 4 (05) :566-572